About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Utility of Adding MR Fusion to Standard US Guided Prostate Biopsy

NCT05064111·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Arizona

Age

18–any

Sex

MALE

Healthy volunteers

Not accepted

You may be eligible if

1. Able to give informed consent
2. Male - age \> 18
3. mpMRI within the previous 6 months (PIRADS 3,4,5, all stages of PCa)
4. Scheduled for TRUS biopsy for prostate lesion or mass

You may not be if

1. Age under 18 years of age.
2. Female
3. Pre-existing blood dyscrasias
4. Inability to perform TRUS due to anal sphincter closure/surgery
5. Patients needing general anesthesia
6. Patients allergic to lidocaine
7. Patients allergic or unable to take antibiotics

The record

StatusSuspended

PhaseNo phase

Taking part100

StartedNov 2026

UpdatedDec 3, 2025

Conditions

Prostate Cancer Prostate Adenocarcinoma

Where1

University of Arizona
Tucson, Arizona, United States

Clareo Health | Utility of Adding MR Fusion to Standard US Guided Prostate Biopsy